<DOC>
	<DOCNO>NCT02022930</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Hydros-TA Joint Therapy relief pain due OA knee . Hydros-TA design provide fast act long last pain relief six month single IA injection .</brief_summary>
	<brief_title>Hydros Hydros-TA Joint Therapy Pain Associated With Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Have radiographic evidence within prior 6 month , show radiology report , OA grade 2 3 use KellgrenLawrence Grading OA . Symptoms index knee least 12 month . Fully ambulatory Subject ( ability perform 15 meter walk test ) . Male female Subjects 40 85 year age . BMI &gt; 40 kg Secondary OA ( acute knee injury , rheumatoid arthritis , gout , history joint infection , osteonecrosis , chronic fibromyalgia ) chronic autoimmune disease . Intra articular steroid therapy last 3 month Intra articular viscosupplementation last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
</DOC>